BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 23532518)

  • 1. CCL26/eotaxin-3 is more effective to induce the migration of eosinophils of asthmatics than CCL11/eotaxin-1 and CCL24/eotaxin-2.
    Provost V; Larose MC; Langlois A; Rola-Pleszczynski M; Flamand N; Laviolette M
    J Leukoc Biol; 2013 Aug; 94(2):213-22. PubMed ID: 23532518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial: are all eotaxins created equal?
    Pease JE; Williams TJ
    J Leukoc Biol; 2013 Aug; 94(2):207-9. PubMed ID: 23906965
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration.
    White JR; Lee JM; Dede K; Imburgia CS; Jurewicz AJ; Chan G; Fornwald JA; Dhanak D; Christmann LT; Darcy MG; Widdowson KL; Foley JJ; Schmidt DB; Sarau HM
    J Biol Chem; 2000 Nov; 275(47):36626-31. PubMed ID: 10969084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoregulation of CCL26 synthesis and secretion in A549 cells: a possible mechanism by which alveolar epithelial cells modulate airway inflammation.
    Abonyo BO; Alexander MS; Heiman AS
    Am J Physiol Lung Cell Mol Physiol; 2005 Sep; 289(3):L478-88. PubMed ID: 15863444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine-stimulated human lung alveolar epithelial cells release eotaxin-2 (CCL24) and eotaxin-3 (CCL26).
    Heiman AS; Abonyo BO; Darling-Reed SF; Alexander MS
    J Interferon Cytokine Res; 2005 Feb; 25(2):82-91. PubMed ID: 15695929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CCL11, CCL24, and CCL26-induced degranulation in HL-60 eosinophilic cells by specific inhibitors of MEK1/MEK2, p38 MAP kinase, and PI 3-kinase.
    Badewa AP; Heiman AS
    Immunopharmacol Immunotoxicol; 2003 May; 25(2):145-57. PubMed ID: 12784909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines.
    Shahabuddin S; Ponath P; Schleimer RP
    J Immunol; 2000 Apr; 164(7):3847-54. PubMed ID: 10725746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Overlook to the Characteristics and Roles Played by Eotaxin Network in the Pathophysiology of Food Allergies: Allergic Asthma and Atopic Dermatitis.
    Ahmadi Z; Hassanshahi G; Khorramdelazad H; Zainodini N; Koochakzadeh L
    Inflammation; 2016 Jun; 39(3):1253-67. PubMed ID: 26861136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
    Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
    J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of extravillous trophoblast function by the eotaxins CCL11, CCL24 and CCL26.
    Chau SE; Murthi P; Wong MH; Whitley GS; Brennecke SP; Keogh RJ
    Hum Reprod; 2013 Jun; 28(6):1497-507. PubMed ID: 23477905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory effects of eotaxin, eotaxin-2, and eotaxin-3 on eosinophil degranulation and superoxide anion generation.
    Badewa AP; Hudson CE; Heiman AS
    Exp Biol Med (Maywood); 2002 Sep; 227(8):645-51. PubMed ID: 12192108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin.
    Penido C; Castro-Faria-Neto HC; Vieira-de-Abreu A; Figueiredo RT; Pelled A; Martins MA; Jose PJ; Williams TJ; Bozza PT
    Am J Respir Cell Mol Biol; 2001 Dec; 25(6):707-16. PubMed ID: 11726396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications.
    Amerio P; Frezzolini A; Feliciani C; Verdolini R; Teofoli P; De Pità O; Puddu P
    Curr Drug Targets Inflamm Allergy; 2003 Mar; 2(1):81-94. PubMed ID: 14561178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogeny of the eotaxins in human lung.
    Haley KJ; Sunday ME; Porrata Y; Kelley C; Twomey A; Shahsafaei A; Galper B; Sonna LA; Lilly CM
    Am J Physiol Lung Cell Mol Physiol; 2008 Feb; 294(2):L214-24. PubMed ID: 18055844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils.
    White JR; Imburgia C; Dul E; Appelbaum E; O'Donnell K; O'Shannessy DJ; Brawner M; Fornwald J; Adamou J; Elshourbagy NA; Kaiser K; Foley JJ; Schmidt DB; Johanson K; Macphee C; Moores K; McNulty D; Scott GF; Schleimer RP; Sarau HM
    J Leukoc Biol; 1997 Nov; 62(5):667-75. PubMed ID: 9365122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of CCL11 and CCL26 is associated with activated eosinophils in bullous pemphigoid.
    Günther C; Wozel G; Meurer M; Pfeiffer C
    Clin Exp Immunol; 2011 Nov; 166(2):145-53. PubMed ID: 21985360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL11 (Eotaxin) induces CCR3-dependent smooth muscle cell migration.
    Kodali RB; Kim WJ; Galaria II; Miller C; Schecter AD; Lira SA; Taubman MB
    Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1211-6. PubMed ID: 15130922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent manner.
    Bochner BS; Bickel CA; Taylor ML; MacGlashan DW; Gray PW; Raport CJ; Godiska R
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):527-32. PubMed ID: 10069890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of eotaxin 1/CCL11, eotaxin 2/CCL24 and eotaxin 3/CCL26 expression in lesional and non-lesional skin of patients with atopic dermatitis.
    Owczarek W; Paplińska M; Targowski T; Jahnz-Rózyk K; Paluchowska E; Kucharczyk A; Kasztalewicz B
    Cytokine; 2010 May; 50(2):181-5. PubMed ID: 20236835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL26-targeted siRNA treatment of alveolar type II cells decreases expression of CCR3-binding chemokines and reduces eosinophil migration: implications in asthma therapy.
    Errahali YJ; Taka E; Abonyo BO; Heiman AS
    J Interferon Cytokine Res; 2009 Apr; 29(4):227-39. PubMed ID: 19203252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.